DreaMed is a pioneering healthcare technology company specializing in AI-driven solutions for diabetes care. It provides expert-level treatment recommendations by transforming patient data through its FDA-cleared software, endo. digital. This cloud-based SaaS platform enables any healthcare provider, from primary care physicians to pharmacists, to deliver expert diabetes care both remotely and in person. DreaMed's technology improves clinical outcomes, increases efficiency, and enhances patient engagement. The company is at the forefront of integrating advanced technology into patient care, addressing the shortage of diabetes specialists globally, and ensuring that expert care is accessible to all.